Overview

Bioequivalence Study for Desloratadine OD Tablets 5 mg Under Fasting Condition

Status:
Completed
Trial end date:
2006-02-01
Target enrollment:
Participant gender:
Summary
This is an open label, randomised, single dose, 2-way crossover, comparative bioequivalence study.
Phase:
Phase 1
Details
Lead Sponsor:
Dr. Reddy's Laboratories Limited
Treatments:
Desloratadine
Loratadine